Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | D(3) dopamine receptor | ||
Ligand | BDBM50207117 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | ChEMBL_1630050 (CHEMBL3872756) | ||
Ki | 0.240000±n/a nM | ||
Citation | Chen, XW; Sun, YY; Fu, L; Li, JQ Synthesis and pharmacological characterization of novel N-(trans-4-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)cyclohexyl)amides as potential multireceptor atypical antipsychotics. Eur J Med Chem123:332-353 (2016) [PubMed] Article | ||
More Info.: | Get all data from this article, Assay Method | ||
D(3) dopamine receptor | |||
Name: | D(3) dopamine receptor | ||
Synonyms: | DOPAMINE D3 | DRD3 | DRD3_HUMAN | Dopamine D3 receptor | Dopamine D3 receptor (D3) | Dopamine D3 receptor (D3R) | Dopamine receptor | Dopamine receptor (D3) | Dopamine receptor D3 | ||
Type: | n/a | ||
Mol. Mass.: | 44243.43 | ||
Organism: | Homo sapiens (Human) | ||
Description: | n/a | ||
Residue: | 400 | ||
Sequence: |
| ||
BDBM50207117 | |||
n/a | |||
Name | BDBM50207117 | ||
Synonyms: | CHEMBL3970746 | ||
Type | Small organic molecule | ||
Emp. Form. | C24H29N5O4S | ||
Mol. Mass. | 483.583 | ||
SMILES | [O-][N+](=O)c1ccc2c(nsc2c1)N1CCN(CC[C@H]2CC[C@@H](CC2)NC(=O)c2ccco2)CC1 |r,wU:18.19,wD:21.26,(18.7,-13.51,;18.34,-15.04,;16.9,-15.51,;19.52,-16.08,;20.96,-15.56,;22.13,-16.64,;21.77,-18.12,;22.7,-19.36,;21.77,-20.59,;20.34,-20.13,;20.34,-18.59,;19.16,-17.56,;24.24,-19.36,;25.01,-20.69,;26.55,-20.69,;27.32,-19.36,;28.86,-19.36,;29.62,-20.69,;31.16,-20.69,;31.93,-19.36,;33.47,-19.36,;34.24,-20.69,;33.47,-22.02,;31.93,-22.02,;35.78,-20.69,;36.55,-22.02,;35.83,-23.41,;38.09,-21.97,;38.9,-20.64,;40.39,-21.05,;40.49,-22.59,;39.06,-23.15,;26.55,-18.02,;25.01,-18.02,)| | ||
Structure |